HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Berntorp Selected Research

anti-inhibitor coagulant complex

9/2013Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study.
1/2011Identifying non-responsive bleeding episodes in patients with haemophilia and inhibitors: a consensus definition.
1/2010FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations.
1/2009Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors.
3/2008Value added: increasing the power to assess treatment outcome in joint haemorrhages.
11/2003Monitoring the bioavailability of FEIBA with a thrombin generation assay.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E Berntorp Research Topics

Disease

47Hemophilia A (Haemophilia)
04/2018 - 10/2000
28Hemorrhage
07/2018 - 01/2000
9von Willebrand Diseases (von Willebrand's Disease)
07/2018 - 04/2001
5Hemophilia B (Haemophilia B)
04/2016 - 10/2000
5Joint Diseases (Joint Disease)
11/2012 - 05/2003
3Venous Thrombosis (Deep-Vein Thrombosis)
04/2013 - 11/2000
3Thrombosis (Thrombus)
07/2012 - 08/2001
2Type 3 von Willebrand Disease
09/2015 - 06/2007
1Metrorrhagia (Spotting)
07/2016
1Angiodysplasia
05/2015
1Inborn Genetic Diseases (Disease, Hereditary)
01/2015
1Virus Diseases (Viral Diseases)
07/2014
1Hepatitis
05/2013
1Thrombophlebitis
04/2013
1Pulmonary Embolism
04/2013
1Injection Site Reaction
06/2011
1Osteoporosis
05/2010
1Hypersensitivity (Allergy)
01/2010
1Thrombophilia
02/2009
1Pre-Eclampsia (Preeclampsia)
02/2009
1Synovitis
06/2007
1Critical Illness (Critically Ill)
10/2002
1Infections
07/2001
1Hepatitis C
04/2001
1Liver Diseases (Liver Disease)
04/2001
1Chronic Hepatitis C
04/2001
1Inherited Blood Coagulation Disorders
01/2001
1Myocardial Infarction
10/2000
1Venous Thromboembolism
06/2000
1Protein C Deficiency
06/2000
1Epistaxis (Nosebleed)
04/2000

Drug/Important Bio-Agent (IBA)

19Factor VIII (Coagulation Factor VIII)IBA
04/2018 - 01/2001
12Blood Coagulation Factors (Coagulation Factor)IBA
07/2016 - 01/2001
9von Willebrand FactorIBA
04/2018 - 01/2007
9recombinant FVIIa (rFVIIa)FDA Link
06/2011 - 01/2000
7Factor IX (Coagulation Factor IX)FDA LinkGeneric
04/2016 - 01/2001
7ThrombinFDA Link
07/2015 - 01/2003
6AntibodiesIBA
04/2018 - 05/2007
6anti-inhibitor coagulant complexIBA
09/2013 - 11/2003
4Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
09/2015 - 11/2006
4Factor VIIa (Activated Factor VII)IBA
06/2011 - 04/2000
3Neutralizing AntibodiesIBA
03/2017 - 06/2011
3Prothrombin (Factor II)IBA
07/2015 - 10/2000
3Hemostatics (Antihemorrhagics)IBA
07/2015 - 08/2001
3human F8 proteinFDA Link
11/2008 - 09/2003
3Warfarin (Coumadin)FDA LinkGeneric
06/2000 - 01/2000
2EpitopesIBA
01/2013 - 09/2003
2Pharmaceutical PreparationsIBA
03/2012 - 06/2011
2von Willebrand factor drug combination factor VIIIIBA
11/2008 - 01/2007
2Vitamin KFDA Link
06/2000 - 04/2000
1AntigensIBA
04/2018
1prothrombin complex concentrates (PPSB)IBA
04/2018
1Capsules (Microcapsules)IBA
05/2015
1Proteins (Proteins, Gene)FDA Link
01/2013
1Therapeutic UsesIBA
07/2012
1A-factor (Streptomyces)IBA
05/2010
1GadoliniumIBA
06/2007
1Contrast MediaIBA
06/2007
1Immunoglobulin G (IgG)IBA
12/2006
1Staphylococcal Protein A (Protein A)IBA
12/2006
1Biomarkers (Surrogate Marker)IBA
11/2006
1Biological ProductsIBA
11/2006
1Serum AlbuminIBA
09/2004
1AlbuminsIBA
09/2004
1recombinant factor VIII SQIBA
09/2003
1SolutionsIBA
08/2001
1Tranexamic Acid (AMCA)FDA Link
08/2001
1N-(4-isothiocyanatophenethyl)spiperoneIBA
07/2001
1InterferonsIBA
04/2001
1Ribavirin (Virazole)FDA LinkGeneric
04/2001
1Interferon-alpha (Interferon Alfa)IBA
04/2001
1Genetic Markers (Genetic Marker)IBA
11/2000
1Antigen-Antibody Complex (Immune Complex)IBA
10/2000
1Protein CIBA
06/2000

Therapy/Procedure

24Therapeutics
04/2018 - 01/2001
2Intravenous Injections
06/2011 - 03/2003
1Ambulatory Care (Outpatient Care)
07/2018
1Injections
11/2017
1Catheters
04/2013
1Orthopedic Procedures
01/2004
1Intravenous Administration
01/2001